Learn
Delve into dermatology diseases with new approaches from conventional to complementary care.
Topics
Explore a broad spectrum of dermatological conditions and topics to enhance your practice.
Training Programs
Expert led instruction for every level of patient care.
Log in to see enrolled program content.
Conferences
Gain practical insights and meet new colleagues.
Hover over a conference to view recordings.
Join Us
The largest integrative dermatology community.
Safety of Biologics: The Risk of Infection and Malignancy With Biologic Therapy
Course Overview
Preview what you'll learn in this program
What You'll Learn
One-third of adult psoriasis patients develop symptoms starting in childhood. Learn about the diagnostic challenges and management of childhood psoriasis.
Faculty
Editors
Accreditation Information
One-third of adult psoriasis patients develop symptoms starting in childhood. Learn about the diagnostic challenges and management of childhood psoriasis.
Learning Objectives
- Classify the common safety precaution for biologics based on class of medications.
- Analyze the data from clinical trials and registry studies.
✨ Ready to Begin Your Journey? ✨
Enroll now to start the course and unlock all learning materials
Safety of Biologics
Complete the previous section to unlock this lesson
Safety of Biologics: The Risk of Infection and Malignancy with Biologic Therapy Module
Complete the previous section to unlock this lesson
Course Discussion
Join the conversation with fellow learners
Also Recommended
Extracutaneous Comorbidities of Psoriasis: Joint, Cardiovascular, Metabolic, and Psychological Impact
Assessing Metabolic Syndrome in a Patient with Psoriasis
How to Manage a Patient with Psoriasiform Dermatitis following Immunotherapy Treatment
Case-Based Learning: Difficult Psoriasis – Challenges from the Clinic
